Best Practices

The investigative oral Factor Xa inhibitor apixaban could prevent strokes among atrial fibrillation patients better than current treatments—and may be able to perform that task without a risk of excessive bleeding.

Funding problems hampering maternal and child care, Health Council says

Study based on Ontario Health Insurance Plan data also shows 14- to 19-year-olds most likely to need revision

Review of herbal menopause treatments.

Review finds little evidence to support benefit for most medical treatments in children with autism spectrum disorders.

Risk of acute kidney injury increased within one year of starting the antiobesity drug orlistat, study finds.